Dec 8 (Reuters) - Hochdorf Holding AG HOCN.S :
* HOCHDORF HOLDING-HOCHDORF GROUP BOARD SOLD 51% MAJORITY
STAKE IN
COMPANIES OF PHARMALYS GROUP TO PHARMALYS INVEST HOLDING,
CONTROLLED BY AMIR MECHRIA
* HOCHDORF- COOPERATION BETWEEN HOCHDORF GROUP AND PHARMALYS
GROUP
IS TO BE CONTINUED
* HOCHDORF HOLDING - PHARMALYS INVEST HOLDING REMAINS
LARGEST
SHAREHOLDER OF HOCHDORF GROUP
* HOCHDORF HOLDING-AFTER EXAMINING VARIOUS OPTIONS,
PHARMALYS
SHARES HAVE NOW BEEN SOLD; SELLING PRICE IS AROUND CHF 100
MILLION
* HOCHDORF- FOCUS OF HOCHDORF GROUP ON HIGH-GROWTH BABY CARE
DIVISION REMAINS UNCHANGED DESPITE SALE OF PHARMALYS SHARES
* HOCHDORF- PHARMALYS INTENDS TO CONTINUE MARKETING SWISS
BABY
FOOD PRODUCED BY HOCHDORF
* HOCHDORF- HOCHDORF WILL IN FUTURE INCREASINGLY WORK WITH
TRADITIONAL SWISS BRAND BIMBOSAN AND BABINA BRAND
* HOCHDORF - WITH SALE OF PHARMALYS INVESTMENT, HOCHDORF
GROUP
REGAINS ITS STRATEGIC FLEXIBILITY AND TAKES AN IMPORTANT STEP
TOWARDS FINANCIAL RECOVERY
* A CLEARLY NEGATIVE RESULT IS STILL EXPECTED FOR CURRENT
FISCAL
YEAR
* HOCHDORF-NEGATIVE RESULT FOR FY IS EXPECTED DUE TO
CURRENTLY LOW
SALES IN BABY CARE SEGMENT & TECHNICAL CHALLENGES BY NEW SPRAY
TOWER LINE IN SULGEN
Source text for Eikon: ID:nPex9dVYwa
Further company coverage: HOCN.S
((Reuters.Briefs@thomsonreuters.com;))